• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Asswood





Similar threads

Replies
3
Views
7K
Caswood
Anonymous
Replies
4
Views
4K
Caswood
Anonymous